Effects of Autoantibodies Against β1-Adrenoceptor on Cardiac Myocytes
Author Information
Author(s): Wang Yuan-yuan, Ma Zhi-Yong, Li Xiao-Dong, Wang Jian-chun, Zhang Wei, Li Li, Zhang Yun
Primary Institution: Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education and Chinese Ministry of Public Health, Jinan, China
Hypothesis
Autoantibodies targeting the β1-adrenergic receptor may have a pathogenic role in the progression of heart failure.
Conclusion
Serum positive for autoantibodies against the β1-adrenoceptor decreases the current density of I ss in mouse cardiomyocytes in a concentration-dependent manner.
Supporting Evidence
- AAB-β1-positive serum had no effect on the activity of I to.
- AAB-β1-positive serum significantly decreased I ss at dilutions of 1:10, 1:20, and 1:50.
- The EC50 of AAB-β1-positive serum was found to be 1/60.24.
Takeaway
The study found that certain antibodies in the blood of heart failure patients can make heart cells less effective at sending electrical signals, which could lead to heart problems.
Methodology
The study involved electrophysiological recordings of mouse cardiac myocytes exposed to serum from patients with heart failure to assess the effects on potassium currents.
Limitations
The study did not investigate the mechanism behind the inhibitory effect of AAB-β1 on I ss.
Participant Demographics
Patients were Chinese individuals with stable congestive heart failure and left ventricular ejection fractions ≤45%.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website